WuXi BioLogics heads to Hong Kong for $300m IPO
China’s WuXi BioLogics is looking south of the border to Hong Kong to go public, preparing an IPO that could raise $300m, according to a banker close to the deal.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts